Nail changes as manifestation of systemic disease in COVID‐19 infection
2021; Wiley; Volume: 35; Issue: 8 Linguagem: Inglês
10.1111/jdv.17273
ISSN1468-3083
AutoresSonia Sofìa Ocampo‐Garza, Jorge Ocampo‐Candiani, Elisa Camela, Maria Vastarella, Gabriella Fabbrocini, Massimiliano Scalvenzi, Alessia Villani,
Tópico(s)Streptococcal Infections and Treatments
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 35, Issue 8 p. e474-e475 Letter To The Editor Nail changes as manifestation of systemic disease in COVID-19 infection S.S. Ocampo-Garza, S.S. Ocampo-Garza orcid.org/0000-0002-0508-5117 Departamento de Dermatología, Universidad Autónoma de Nuevo León, Hospital Universitario ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, México Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorJ. Ocampo-Candiani, J. Ocampo-Candiani orcid.org/0000-0002-0213-0031 Departamento de Dermatología, Universidad Autónoma de Nuevo León, Hospital Universitario ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, MéxicoSearch for more papers by this authorE. Camela, E. Camela Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorM. Vastarella, M. Vastarella orcid.org/0000-0002-0682-8680 Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorG. Fabbrocini, G. Fabbrocini Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorM. Scalvenzi, M. Scalvenzi Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorA. Villani, Corresponding Author A. Villani [email protected] orcid.org/0000-0001-6430-268X Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy *Correspondence: A. Villani. E-mail: [email protected]Search for more papers by this author S.S. Ocampo-Garza, S.S. Ocampo-Garza orcid.org/0000-0002-0508-5117 Departamento de Dermatología, Universidad Autónoma de Nuevo León, Hospital Universitario ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, México Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorJ. Ocampo-Candiani, J. Ocampo-Candiani orcid.org/0000-0002-0213-0031 Departamento de Dermatología, Universidad Autónoma de Nuevo León, Hospital Universitario ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, MéxicoSearch for more papers by this authorE. Camela, E. Camela Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorM. Vastarella, M. Vastarella orcid.org/0000-0002-0682-8680 Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorG. Fabbrocini, G. Fabbrocini Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorM. Scalvenzi, M. Scalvenzi Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalySearch for more papers by this authorA. Villani, Corresponding Author A. Villani [email protected] orcid.org/0000-0001-6430-268X Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy *Correspondence: A. Villani. E-mail: [email protected]Search for more papers by this author First published: 08 April 2021 https://doi.org/10.1111/jdv.17273Citations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Senturk N, Ozdemir H. Onychomadesis following COVID-19 infection: Is there a relationship? Dermatol Ther 2020; 33: 2–3. 10.1111/dth.14309 Web of Science®Google Scholar 2Méndez-Flores S, Zaladonis A, Valdes-Rodriguez R. COVID-19 and nail manifestation: be on the lookout for the red half-moon nail sign. Int J Dermatol 2020; 59: 1414. 10.1111/ijd.15167 CASPubMedWeb of Science®Google Scholar 3Alobaida S, Lam JM. Beau lines associated with COVID-19. CMAJ 2020; 192: E1040. 10.1503/cmaj.201619 CASPubMedWeb of Science®Google Scholar 4Ide S, Morioka S, Inada M, Ohmagari N. Beau's lines and leukonychia in a COVID-19 patient. Intern Med 2020; 59: 3259. 10.2169/internalmedicine.6112-20 PubMedWeb of Science®Google Scholar 5Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM. The red half-moon nail sign: a novel manifestation of coronavirus infection. J Eur Acad Dermatology Venereol 2020; 34: e663–e665. 10.1111/jdv.16747 CASPubMedWeb of Science®Google Scholar 6Tammaro A, Adebanjo GAR, Erasmus HP et al. Transverse orange nail lesions following SARS-CoV-2 infection. Dermatol Ther 2021; 34: 2–3. 10.1111/dth.14688 Web of Science®Google Scholar Citing Literature Volume35, Issue8August 2021Pages e474-e475 ReferencesRelatedInformation
Referência(s)